Dáil Éireann Debate, Tuesday - 20 November 2018
417. Deputy James Browne asked the Minister for Health the number of drugs considered by the rare disease technology review committee; the names of the drugs; and if he will make a statement on the matter. [47997/18]
View answerThe HSE has statutory responsibility for decisions on pricing and reimbursement of medicines, in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013; therefore, the matter has been referred to the HSE for reply to the Deputy.
